The insulin glargine market is estimated to be valued at US$ 6178.14 Mn in 2023 and is expected to exhibit a CAGR of 6.28% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:
Strength:
1) Insulin glargine has proven effective at controlling blood sugar levels over a 24-hour period with just one...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian